1Wolden SL, Zelefsky M J, Hunt M, et al. Failure of a 3D conformal boost to improve radiotherapy for nasopharyngel carcinoma. Int J Radiat Oncol Biol Phys, 2001,49:1229-1234.
2Leibel SA, Kutcher GJ, Harrison LB, et al. Improved dose in distribution for 3D conformal boost treatment in carcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys, 1991,20: 823-833.
3Leibel SA, Ling CC, Kutcher GJ, et al. The biological basis for conformal three-demensional radioation therapy. Int J Radiat Oncol Biol Phys,1991,20: 803-811.
4Suzanne LW, Michoel JZ, Margie AH, et al. Failure of a 3D conformal boost to improve radiotherapy for nasopharyneal carcinoma. Int J Radiat Oncol Biol Phys, 2001,49:1229-1234.
5Sanguineti G, Geara GB, Garden AS, et al. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control (see comments). Int J Radiat Oncol Biol Phys, 1997,37:985-996.
6Taamma A, Fandi A, Azlin, et al. Phase Ⅱ trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with lically advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type. Cancer, 1999,86:1
7Takeshi N, Hiroki S, Kenji K, et al. Three-dimensional small-volume irradiation for residual or recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 2000,48: 495-500.
8Louis P, Michael S, Paul W, et al. How one defines intensity-modulated radiation therapy. Int J Ratiat Oncol Biol Phys, 2003,56: 609-610.
9Sanford LM, John MB, Francis JB, et al. Potential clinical efficacy of intensity-modulated conformal therapy. Int J Radiat Oncol Biol Phys,1998,40:483-495.
10Hsiung CY, Yorke ED, Chui CS. Intensity-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 2002,53: 638-647.
二级参考文献16
1Lee AW, Foo W, Law SC, et al. Recurrent nasopharyngeal carcinoma:the puzzles of long latency. Int J Radiat Oncol Biol Phys, 1999, 44:149-156.
2Woo SY, Sanders M, Grant W,et al. Does the "peacock" have anything to do with radiationtherapy? Int J Radiat Oncol Biol Phys, 1994,29:213-214.
3Sanguineti G, Geara FB, Garden AS, et al. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Int J Radiat Oncol Biol Phvs, 1997,37:985-996.
4Bin S Teh, Shian Y Woo, E Brian Butler. Intensity modulated radiation therapy(IMRT) : a new promising technology in radiation oncology. The Oncologist, 1999, 4:433-442.
5Xia Ping, Fu Karen K, Wong Gordon W, et al. Comparison of treatment plans involving intensity modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phvs, 2000, 48:320-337.
6Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys, 1991, 21: 109-122.
7Yang TS, Ng KT, Wang HM, et al. Prognostic factors of locoregionally recurrent nasopharyngeal carcinoma: a retrospective review of 182 cases.Am J Clin Oncol, 1996,19: 337-343.
